Literature DB >> 16979581

A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome.

Edward B Blanchard1, Jeffrey M Lackner, Kathryn Sanders, Susan Krasner, Laurie Keefer, Annette Payne, Gregory D Gudleski, Leonard Katz, Dianna Rowell, Mark Sykes, Eric Kuhn, Rebecca Gusmano, Ann Marie Carosella, Rebecca Firth, Lisa Dulgar-Tulloch.   

Abstract

We randomized, at two sites, 210 patients with Rome II diagnosed irritable bowel syndrome (IBS), of at least moderate severity, to one of three conditions: group-based cognitive therapy (CT; n=120), psychoeducational support groups (n=46) as an active control, or intensive symptom and daily stress monitoring (n=44). One hundred eighty-eight participants completed the initial treatment. Those in symptom monitoring were then crossed over to CT. For an intent to treat analysis on a composite GI symptom measure derived from daily symptom diaries, both CT and the psychoeducational support groups were significantly more improved than those in the intensive symptom monitoring condition, but the CT and psychoeducational support group did not differ. Among treatment completers on the same composite measure of GI symptoms, again, both CT and psychoeducational support groups were statistically superior to symptom monitoring but did not differ on the symptom composite, or on any other measure. On individual IBS symptoms, both CT and psychoeducational support were statistically superior to symptom monitoring on reductions in abdominal pain and tenderness and for flatulence. Patient global ratings at the end of treatment showed the two active conditions statistically superior to symptom monitoring on change in Bowel Regularity, with CT superior to symptom monitoring on reduction in overall pain and in improvement in sense of well-being. Three-month follow-up data on 175 patients revealed maintenance of significant improvement or continued significant improvement on all IBS symptoms, including the McGill Pain Questionnaire. Group CT and psychoeducational support groups continued not to differ on any measure. We thus conclude that group CT is not superior to an attention placebo control condition.

Entities:  

Mesh:

Year:  2006        PMID: 16979581     DOI: 10.1016/j.brat.2006.07.003

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  23 in total

Review 1.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 2.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

Review 3.  Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.

Authors:  Jason E Bonner; A Sidney Barritt; Michael W Fried; Donna M Evon
Journal:  Dig Dis Sci       Date:  2012-04-07       Impact factor: 3.199

4.  Neonatal maternal separation in the rat impacts on the stress responsivity of central corticotropin-releasing factor receptors in adulthood.

Authors:  Dervla O'Malley; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2010-05-25       Impact factor: 4.530

5.  The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Laurie Keefer; James Jaccard; Rebecca Firth; Darren Brenner; Jason Bratten; Laura J Dunlap; Changxing Ma; Mark Byroads
Journal:  Contemp Clin Trials       Date:  2012-07-28       Impact factor: 2.226

6.  Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions.

Authors:  Monica E Jarrett; Kevin C Cain; Robert L Burr; Vicky L Hertig; Sheldon N Rosen; Margaret M Heitkemper
Journal:  Am J Gastroenterol       Date:  2009-08-18       Impact factor: 10.864

7.  Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.

Authors:  Jeffrey M Lackner; James Jaccard; Susan S Krasner; Leonard A Katz; Gregory D Gudleski; Kenneth Holroyd
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-04       Impact factor: 11.382

Review 8.  Complementary and alternative medicine for treatment of irritable bowel syndrome.

Authors:  Yi-Hao A Shen; Richard Nahas
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

Review 9.  Social learning contributions to the etiology and treatment of functional abdominal pain and inflammatory bowel disease in children and adults.

Authors:  Rona L Levy; Shelby L Langer; William E Whitehead
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

10.  How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial.

Authors:  Jeffrey M Lackner; James Jaccard; Susan S Krasner; Leonard A Katz; Gregory D Gudleski; Edward B Blanchard
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.